摘要在中国经济高速平稳发展的今天，伴随着市场的涨跌，企业价值评估越来越被企业重组和并购,投资和融资活动所重视。价值评估已经引起了金融界人士的高度关注，它被视为企业决策的重要参考依据以及企业生产和创新能力的代表。由于生物科技行业的发展和我国医疗行业技术水平的提高，生物医药行业已经成为国家重点关注的高速发展行业，在我国经济中所占地位越来越重要。生物制药产业在十二五规划中已经处于支柱行业的地位，被社会理解为新的投资热点。因此,对生物医药行业进行价值评估，可以为该行业指出未来合适的发展方向，使企业的竞争力得到增强，使企业的管理得到改善，使企业的可持续经营得以实现。86417

    本文以此作为切入点,在理论分析的基础上,首先总结了生物制药行业的基本特征,和中国生物医药产业的发展情况,明确本文的写作目的;其次,根据当前市场价格的反应和估值理论,选择华兰生物进行了分析;最后,在分析结果的基础上提供投资策略,从而为生物医药类企业上市公司内在价值提升和投资者进行合理决策提供正确方向,以促进生物医药产业的平稳较快发展。

毕业论文关键词：生物医药行业；价值评估；决策方向

Intrinsic Value Estimation of Biological Pharmaceutical Listed Company

Abstract With China's economic development and maturation of the capital market, corporate restructuring and mergers and acquisitions, investment and financing activities more and more attention to enterprise value influence。 The enterprise value evaluation has become an important research direction of the financial sector, it is an important basis for decision-making, but also represents the enterprise value creation ability。

Due to the development of biotechnology industry and the improvement of the technology level of medical industry in our country, the biomedical industry has become the focus of the country's high speed development industry, which is becoming more and more important。 Bio pharmaceutical industry has become a pillar industry of the national economy, but also a new investment concerns。 So, the evaluation of bio pharmaceutical industry research, bio pharmaceutical companies provide clear direction of development, enterprise competitiveness, improve enterprise management, help the enterprise to realize sustainable development。

For this point, related to the theoretical analysis as the foundation, this paper firstly summarizes the basic characteristics of bio pharmaceutical industry and development situation, clear the purpose of writing this paper; secondly, based on responses to the current market price, valuation theory and prevention selects 5 listed companies according to the analysis。 Finally, according to the results of the analysis provide investment strategy, and bio pharmaceutical listed companies intrinsic value and enhance investor decision-making direction provide a reference to promote steady and rapid development of the health of China's bio pharmaceutical industry。

Keywords:Bio-pharmaceutical industry; Value measurement; Decision-making direction

目 录

1。生物医药类上市公司基本特点

1。1生物医药行业普遍特点 1

1。2中国生物医药上市公司特点 2

2。中国生物医药行业归纳分析 2

2。1市场分布的特点 2

2。2中国代表性的生物医药公司基本面 3

2。3类别归纳分析 4

3。行业发展特征分析 生物类医药上市公司的内在价值估计:http://www.youerw.com/kuaiji/lunwen_105678.html